Investigating COPD prevalence in socially vulnerable individuals using a mobile clinic
A Study of the Incidence and Treatment of Impaired Lung Function Among Socially Vulnerable Individuals at a Street Level
This study looks at how common Chronic Obstructive Pulmonary Disease (COPD) is among people in need who visit a mobile clinic in Denmark to see if they have it more often than others and to learn about their experiences with screening and treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 511 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Hvidovre University Hospital Academic / other |
| Locations | 1 site (Copenhagen) |
| Trial ID | NCT05660460 on ClinicalTrials.gov |
What this trial studies
This trial examines the prevalence of Chronic Obstructive Pulmonary Disease (COPD) among socially vulnerable individuals who interact with a mobile clinic in the Capital Region of Denmark. It consists of three sub-studies: a cross-sectional study to assess COPD prevalence, a cohort study to evaluate the impact of opportunistic screening, and a qualitative study to understand patient experiences with screening and treatment. The study aims to highlight the higher incidence of COPD in this population compared to the general public and monitor significant variables related to treatment and health outcomes over a year.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 and older who are socially vulnerable, including those affected by homelessness, drug abuse, or mental illness.
Not a fit: Patients who do not have a Danish civil registration number or are unable to communicate in Danish or English may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved screening and treatment strategies for COPD in socially vulnerable populations.
How similar studies have performed: Other studies have indicated that targeted screening in vulnerable populations can yield significant health insights, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Able to speak and understand Danish or English to such an extent that informed consent can be obtained Exclusion Criteria: \- Not having a Danish civil registration number, since foreign patients do not have free access to examinations and medical treatment, and cannot be followed up in the national patient registry
Where this trial is running
Copenhagen
- Brugernes Akademi — Copenhagen, Denmark (Recruiting)
Study contacts
- Principal investigator: Charlotte S Ulrik — Amager and Hvidovre Hospital
- Study coordinator: Jannet van der Veen
- Email: jannet@brugernesakademi.dk
- Phone: +45 21157392
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.